A recent study suggests mRNA vaccines can make some tumours more responsive to immunotherapy, lowering the risk of death among patients who received the shots within 100 days of starting treatment. However, experts urge caution, noting that proper clinical trials are still needed to prove a direct link
firstpost.com
